Article
A Network-Biology led Computational Drug repurposing Strategy to prioritize therapeutic options for COVID-19
2021-01-12
Abstract excerpt
The alarming pandemic situation of novel Severe Acute Respiratory Syndrome Coronavirus 2 (nSARS-CoV-2) infection, high drug development cost and slow process of drug discovery have made repositioning of existing drugs for therapeutics a popular alternative. It involves the repurposing of existing safe compounds which results in low overall development costs and shorter development timeline. In the present study, a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 201b7452-22f7-5210-8faa-cd55374691e2
- DOI
- 10.21203/rs.3.rs-141650/v1
